Effect of rifampin and bacitracin on nasal carriers of Staphylococcus aureus.

Anterior nares cultures from 664 hospital personnel identified 165 (24.8%) as carriers of Staphylococcus aureus. Persistent carriers (17.8%) were identified and randomly assigned to one of four treatment groups: rifampin (600 mg once a day for 5 days), bacitracin ointment (topically applied three ti...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: McAnally, T P, Lewis, M R, Brown, D R
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 1984
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC185544/
https://ncbi.nlm.nih.gov/pubmed/6732212
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller